133 related articles for article (PubMed ID: 27998583)
21. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study.
Jaspers L; Budiningsih S; Wolterbeek R; Henderson FC; Peters AA
Vaccine; 2011 Oct; 29(44):7785-93. PubMed ID: 21821079
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus knowledge, vaccine acceptance, and vaccine series completion among female entertainment and sex workers in Phnom Penh, Cambodia: the Young Women's Health Study.
Wadhera P; Evans JL; Stein E; Gandhi M; Couture MC; Sansothy N; Sichan K; Maher L; Kaldor J; Page K; ; Kien
Int J STD AIDS; 2015 Oct; 26(12):893-902. PubMed ID: 25505042
[TBL] [Abstract][Full Text] [Related]
23. Reply from the author.
AlShaikh G
Saudi Med J; 2015 Feb; 36(2):254-5. PubMed ID: 25872237
[No Abstract] [Full Text] [Related]
24. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
[TBL] [Abstract][Full Text] [Related]
25. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
Marek E; Dergez T; Rebek-Nagy G; Kricskovics A; Kovacs K; Bozsa S; Kiss I; Ember I; Gocze P
Vaccine; 2011 Nov; 29(47):8591-8. PubMed ID: 21939711
[TBL] [Abstract][Full Text] [Related]
26. Singaporean women's knowledge of human papillomavirus (HPV) and attitudes toward HPV vaccination.
Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Tay EH
Women Health; 2009 Jun; 49(4):334-51. PubMed ID: 19753508
[TBL] [Abstract][Full Text] [Related]
27. Two or three doses of human papillomavirus vaccine?
Brotherton J
BMJ; 2015 Jan; 350():g7778. PubMed ID: 25568966
[No Abstract] [Full Text] [Related]
28. Peruvian FSWs: understanding HPV and barriers to vaccination.
Brown B; Carcamo C; Blas MM; Valderrama M; Halsey N
Vaccine; 2010 Nov; 28(49):7743-7. PubMed ID: 20932498
[TBL] [Abstract][Full Text] [Related]
29. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
[TBL] [Abstract][Full Text] [Related]
30. Factors affecting knowledge about human papillomavirus and its vaccination programme.
Das A; Madhwapathi V; Spencer A; Williams H; Dearnley E; Brown G; Davies P
J Fam Plann Reprod Health Care; 2014 Apr; 40(2):155. PubMed ID: 24648541
[No Abstract] [Full Text] [Related]
31. Sexual Orientation Identity Disparities in Awareness and Initiation of the Human Papillomavirus Vaccine.
Sterling M
Ann Intern Med; 2015 Dec; 163(12):960. PubMed ID: 26666789
[No Abstract] [Full Text] [Related]
32. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme.
Oteng B; Marra F; Lynd LD; Ogilvie G; Patrick D; Marra CA
Sex Transm Infect; 2011 Feb; 87(1):52-7. PubMed ID: 20956352
[TBL] [Abstract][Full Text] [Related]
33. Global human papillomavirus vaccination: can it be cost-effective?
Crosbie EJ
BJOG; 2012 Jan; 119(2):125-8. PubMed ID: 22168760
[No Abstract] [Full Text] [Related]
34. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus vaccine: a major public health advance.
Baltz BL; Hayney MS
J Am Pharm Assoc (2003); 2006; 46(6):761-2. PubMed ID: 17176694
[No Abstract] [Full Text] [Related]
36. Young adults and acceptance of the human papillomavirus vaccine.
Lenselink CH; Schmeink CE; Melchers WJ; Massuger LF; Hendriks JC; van Hamont D; Bekkers RL
Public Health; 2008 Dec; 122(12):1295-301. PubMed ID: 18619631
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus vaccines: an outsider's point of view.
Trollfors B
Expert Rev Vaccines; 2008 Oct; 7(8):1131-3. PubMed ID: 18844585
[No Abstract] [Full Text] [Related]
38. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010.
Bednarczyk RA; Birkhead GS; Morse DL; Doleyres H; McNutt LA
Vaccine; 2011 Apr; 29(17):3138-43. PubMed ID: 21376797
[TBL] [Abstract][Full Text] [Related]
39. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
Goldstone SE; Vuocolo S
Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
[TBL] [Abstract][Full Text] [Related]
40. HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?
Juraskova I; Bari RA; O'Brien MT; McCaffery KJ
Womens Health Issues; 2011; 21(1):71-9. PubMed ID: 21185992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
